Suppr超能文献

泰国东北部肝门周围胆管癌根治性切除的结果

Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand.

作者信息

Titapun Attapol, Pugkhem Ake, Luvira Vor, Srisuk Tharatip, Somintara Ongart, Saeseow O-Tur, Sripanuskul Anan, Nimboriboonporn Anongporn, Thinkhamrop Bandit, Khuntikeo Narong

机构信息

Attapol Titapun, Ake Pugkhem, Vor Luvira, Tharatip Srisuk, Ongart Somintara, O-tur Saeseow, Anan Sripanuskul, Anongporn Nimboriboonporn, Narong Khuntikeo, Department of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.

出版信息

World J Gastrointest Oncol. 2015 Dec 15;7(12):503-12. doi: 10.4251/wjgo.v7.i12.503.

Abstract

AIM

To examine survival outcomes of perihilar cholangiocarcinoma (PCCA) resection including mortality, morbidity and prognostic factors.

METHODS

Multivariate analyses were carried out based on the survival data of all patients with histologically confirmed PCCA who underwent curative resection at Srinagarind Hospital from January 2006 to December 2011.

RESULTS

There were 29 (19%) cases of intrahepatic CCA that involved hilar and 124 (81%) with hilar bile-duct cancer. R0 resection was carried out on 66 (43.1%) patients of whom 50 (32.7%) also had lymph node metastasis. The other patients underwent R1 resection. The overall 5-year survival rate was 20.6% (95%CI: 13.8-28.4) and median survival time was 19.9 mo. Postoperative mortality was 2%, and 30% of patients had complications. Patients without lymph node metastasis were 60% less likely to die than those with metastasis. Achieving R0 led to a 58% reduction in the chance of mortality as compared to R1.

CONCLUSION

To achieve a better survival outcome, focus should center on performing radical surgery and detection of patients with early stage cancer.

摘要

目的

探讨肝门部胆管癌(PCCA)切除术后的生存结局,包括死亡率、发病率及预后因素。

方法

基于2006年1月至2011年12月在诗里拉吉医院接受根治性切除的所有经组织学确诊为PCCA患者的生存数据进行多因素分析。

结果

29例(19%)肝内胆管癌累及肝门部,124例(81%)为肝门部胆管癌。66例(43.1%)患者行R0切除,其中50例(32.7%)伴有淋巴结转移。其他患者行R1切除。总体5年生存率为20.6%(95%CI:13.8 - 28.4),中位生存时间为19.9个月。术后死亡率为2%,30%的患者出现并发症。无淋巴结转移的患者死亡可能性比有转移的患者低60%。与R1切除相比,实现R0切除可使死亡几率降低58%。

结论

为获得更好的生存结局,应着重进行根治性手术并检测早期癌症患者。

相似文献

1
Outcome of curative resection for perihilar cholangiocarcinoma in Northeast Thailand.
World J Gastrointest Oncol. 2015 Dec 15;7(12):503-12. doi: 10.4251/wjgo.v7.i12.503.
2
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23.
3
Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience.
J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):521-4. doi: 10.1002/jhbp.74. Epub 2014 Jan 27.
4
The prognostic role of lymphovascular invasion and lymph node metastasis in perihilar and intrahepatic cholangiocarcinoma.
Eur J Surg Oncol. 2019 Aug;45(8):1468-1478. doi: 10.1016/j.ejso.2019.04.019. Epub 2019 Apr 25.
5
Survival outcomes of surgical resection in perihilar cholangiocarcinoma in endemic area of O. Viverrini, Northeast Thailand.
Asian J Surg. 2024 Jul;47(7):2991-2998. doi: 10.1016/j.asjsur.2024.03.116. Epub 2024 Mar 21.
6
Surgery for hilar cholangiocarcinoma: the Leeds experience.
Eur J Surg Oncol. 2008 Jul;34(7):787-94. doi: 10.1016/j.ejso.2007.10.005. Epub 2007 Nov 26.
8
[Surgical treatment for perihilar cholangiocarcinoma:a single-center experience].
Zhonghua Wai Ke Za Zhi. 2023 Mar 29;61(5):381-388. doi: 10.3760/cma.j.cn112139-20221229-00550.

引用本文的文献

2
Survival after Surgery among Cholangiocarcinoma Patients Comparing between Mucin Producing and Non-Mucin Producing.
Asian Pac J Cancer Prev. 2024 Jun 1;25(6):2139-2145. doi: 10.31557/APJCP.2024.25.6.2139.
3
Radiographic features predictive of recurrence and survival after surgical resection of perihilar cholangiocarcinoma.
Heliyon. 2024 Mar 29;10(7):e28805. doi: 10.1016/j.heliyon.2024.e28805. eCollection 2024 Apr 15.
4
Role of Wisteria floribunda agglutinin binding glycans in carcinogenesis and metastasis of cholangiocarcinoma.
Histochem Cell Biol. 2024 May;161(5):423-434. doi: 10.1007/s00418-024-02270-4. Epub 2024 Feb 23.
5
Systemic Treatment for Cholangiocarcinoma.
Recent Results Cancer Res. 2023;219:223-244. doi: 10.1007/978-3-031-35166-2_8.
6
Surgery.
Recent Results Cancer Res. 2023;219:147-222. doi: 10.1007/978-3-031-35166-2_7.
7
Epidemiology and Control of Opisthorchis viverrini Infection: Implications for Cholangiocarcinoma Prevention.
Recent Results Cancer Res. 2023;219:27-52. doi: 10.1007/978-3-031-35166-2_3.
8
Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma.
Front Public Health. 2022 Feb 10;10:766023. doi: 10.3389/fpubh.2022.766023. eCollection 2022.
9
Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma.
Cochrane Database Syst Rev. 2021 Sep 13;9(9):CD012814. doi: 10.1002/14651858.CD012814.pub2.

本文引用的文献

1
Surgical management of perihilar cholangiocarcinoma: a Khon Kaen experience.
J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):521-4. doi: 10.1002/jhbp.74. Epub 2014 Jan 27.
2
Role of anatomical right hepatic trisectionectomy for perihilar cholangiocarcinoma.
Br J Surg. 2014 Feb;101(3):261-8. doi: 10.1002/bjs.9383. Epub 2014 Jan 8.
3
Preoperative biliary drainage in patients with hilar cholangiocarcinoma undergoing major hepatectomy.
World J Gastroenterol. 2013 Dec 14;19(46):8731-9. doi: 10.3748/wjg.v19.i46.8731.
4
Adjuvant chemotherapy in resectable cholangiocarcinoma patients.
J Gastroenterol Hepatol. 2013 Dec;28(12):1885-91. doi: 10.1111/jgh.12321.
5
Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand.
Asian Pac J Cancer Prev. 2013;14(1):321-4. doi: 10.7314/apjcp.2013.14.1.321.
6
Left hepatic trisectionectomy for advanced perihilar cholangiocarcinoma.
Br J Surg. 2013 May;100(6):801-7. doi: 10.1002/bjs.9099. Epub 2013 Mar 4.
7
Multicentre European study of preoperative biliary drainage for hilar cholangiocarcinoma.
Br J Surg. 2013 Jan;100(2):274-83. doi: 10.1002/bjs.8950. Epub 2012 Nov 2.
9
Resection with total caudate lobectomy confers survival benefit in hilar cholangiocarcinoma of Bismuth type III and IV.
Eur J Surg Oncol. 2012 Dec;38(12):1197-203. doi: 10.1016/j.ejso.2012.08.009. Epub 2012 Sep 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验